Once inside the presynaptic terminal, amphetamine increases the amounts of monoamine neurotransmitters hinein the cytosol through the inhibition of vesicular monoamine transporter 2 (VMAT2) as well as through disruption of the electrochemical gradients necessary for vesicular transporter function.The primary pharmacology of these drugs is not on